category,datetime,headline,id,image,related,source,summary,url
company,1768260600,AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans,138083219,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,AbbVie (NYSE: ABBV) today announced a voluntary agreement with the Trump administration to further advance access and affordability for Americans while protecting and investing in U.S. pharmaceutical innovation.,https://finnhub.io/api/news?id=e7a4c515bc5f792a4bd6c50b7546cb03065b7cb09461d4f698b817ffff7269a5
company,1768244580,"AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices",138124226,,ABBV,DowJones,"AbbVie Strikes $100 Billion Investment Deal With Trump, Will Lower Medicaid Prices",https://finnhub.io/api/news?id=0de5d602ff3c05efedb8d96f4ea560fd0ff12948965e587f6c6136ac838f6dfa
company,1768240904,"What $6,500 a Month Really Looks Like in Retirement at 67",138078048,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"Retiring at 67 with $6,500 in monthly income places you solidly in middle-class territory, but the financial reality behind that figure is more nuanced than it appears. With average Social Security benefits at $2,017 per month in 2026, a retiree targeting $6,500 needs to generate roughly $4,483 monthly—or $53,796 annually—from personal savings and investments. The ... What $6,500 a Month Really Looks Like in Retirement at 67",https://finnhub.io/api/news?id=6893e956b6faae41cdb1adaa3ed4f00fff9f2f71cae9fb0f95d173a221eb60ef
company,1768238940,Health Care Roundup: Market Talk,138078034,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"Find insight on U.S. pharmaceutical companies’ cash positions, the Thai health-care sector and more in the latest Market Talks covering the health care sector.",https://finnhub.io/api/news?id=eda3cf4f73b150dab1efe606ce157882d4fca763716cba74b6697431d4686de4
company,1768236418,JPM26: AbbVie and RemeGen kick off deals with $5.6bn oncology agreement,138076447,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"AbbVie and RemeGen are the first companies to announce a deal at the J.P Morgan Healthcare Conference 2026, with more deals expected in the coming days.",https://finnhub.io/api/news?id=2666d71eb4ac821fad49b14306d7d3f30e001038b23e3e442277f973faaf74a5
company,1768225860,AbbVie Down 3% in a Month: Why Holding the Stock Still Makes Sense,138075196,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"ABBV stock falls 3% in a month amid takeover rumor denials, but Skyrizi and Rinvoq momentum and a deep pipeline support staying invested.",https://finnhub.io/api/news?id=58765a627d9be58ce6cb0cd8fcb045fda1cc5bb353794f942837148ac1ed4ae8
company,1768222478,JPM26: Revolution Medicines in spotlight as industry gears up for dealmaking spree,138071377,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"Multiple big pharma companies are reported to be circling Revolution, a cancer biotech with a market cap of $23bn.",https://finnhub.io/api/news?id=5f6bd37f57ed8d6e8d3e5d332da6a3b5814c6751e9510a1bd927294c52241b7b
company,1768221000,AbbVie and RemeGen Announce Exclusive Licensing Agreement to Develop A Novel Bispecific Antibody for Advanced Solid Tumors,138071378,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"AbbVie (NYSE: ABBV) and RemeGen today announced an exclusive licensing agreement for the development, manufacturing and commercialization of RC148, a novel investigational Programmed Cell Death-1 (PD-1)/Vascular Endothelial Growth Factor (VEGF)-targeted bispecific antibody. RC148 is currently being developed by RemeGen as a monotherapy and in combination regimens across multiple advanced solid tumors.",https://finnhub.io/api/news?id=28ce3a61ff49f7fccac6a70d57e5d80a6192b11d5a462a9ae71f21549ad3b635
company,1768217040,AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations,138075441,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"AbbVie is paying $650 million for a dual-targeting immunotherapy from China’s RemeGen. Elsewhere, Alnylam missed an earnings target and the FDA flipped its position on a cell therapy from Atara.",https://finnhub.io/api/news?id=4c5cd43b9789dda93c2e7019c0a76364351620a7132db313a44e9fefec4c074b
company,1768215600,"AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States",138071380,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"AbbVie (NYSE: ABBV) and West Pharmaceutical Services (NYSE: WST) announced today a definitive agreement for AbbVie to acquire a device manufacturing facility in Tempe, Arizona and associated intellectual property from West. The acquisition of the manufacturing site will significantly expand AbbVie's drug delivery device manufacturing capabilities and capacity.",https://finnhub.io/api/news?id=ac8939b079978297f76c5203c80b3d85f43c27989f0f3359a46d90ef9f10ea61
company,1768215600,West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie,138071379,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the company has reached a definitive agreement to sell all manufacturing and supply rights for SmartDose® 3.5mL On-Body Delivery System and associated facilities to AbbVie (NYSE: ABBV) for total consideration of $112.5 million at close, subject to working capital and other adjustments. The definitive agreement, which is subject to certain closing condit",https://finnhub.io/api/news?id=eee722e6bd9a5d798dc451e61f082eb755157a413dff8ba85c2570e2848aa6a2
company,1768208700,3 No-Brainer Dividend Stocks to Buy Right Now,138071381,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,The decision about buying these dividend stocks is an easy one.,https://finnhub.io/api/news?id=95738e0352cfce812107dfc8704bfdc1eee3b46614382ced69fe15a2baed2adf
company,1768204800,"Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery",138071382,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,ABBV,Yahoo,"Taiwan-based Formosa Pharmaceuticals (""Formosa"", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd (""Samil"", 000520.KS), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery in South Korea. Samil, established in 1947, is one of the most prominent Korean manufactu",https://finnhub.io/api/news?id=9b6cc42c0641dbad316c64a7e4916a4faa3c7cb0a762fecad63fec1aae4725fe
company,1768204560,AbbVie to License RemeGen Cancer Drug,138124247,,ABBV,MarketWatch,AbbVie to License RemeGen Cancer Drug,https://finnhub.io/api/news?id=1b55d58dfe5bcb54dcd42cdfcc2c22d9d06a12289ffe465d4aef3b5826f94b6f
company,1768199100,"AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma",138124248,,ABBV,MarketWatch,"AbbVie to Acquire Drug Delivery System, Arizona Manufacturing Facility from West Pharma",https://finnhub.io/api/news?id=0ab51f8e2bfcf73d76e73503c3504a620fb9150c35f18992d8973813c686ab04
company,1768194720,Dividend Income: Lanny's November 2025 Summary,138070462,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2221411629/image_2221411629.jpg?io=getty-c-w1536,ABBV,SeekingAlpha,"In November, we (my wife and I) received a dividend income total of $1,489.90. Another $1,000+.",https://finnhub.io/api/news?id=910f66ee15121fb871783a170f718075f6f0c37d0196ad9808ff9942f4b03396
